Quality of life in respiratory allergy.
The HRQL (Health Related Quality of Life) is considered a relevant aspect of pharmacological treatment, since it evaluates the outcomes from the patient's viewpoint. This article reviews the currently available information about HRQL as an outcome measure in Respiratory Allergy. Pertinent abstracts and articles were considered, showing strong evidence that HRQL assessment has emerged as an important parameter in both clinical practice and experimental trials. The different types of questionnaires used in HRQL assessment, the results of studies using those questionnaires and concomitant effect of pharmacologic treatments, are herein reviewed. Moreover, the impact of allergy specialists' care on patients with allergies and the new perspectives in HRQL are discussed.
Baiardini
I
I
Department of Allergy and Respiratory Diseases, DIMI, Genoa University, Genoa, Italy.
Pasquali
M
M
Giardini
A
A
Majani
G
G
Canonica
G W
GW
D001249:Asthma / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D011788:Quality of Life / Q000523:psychology*; D012130:Respiratory Hypersensitivity / Q000188:drug therapy* / Q000523:psychology*; D012220:Rhinitis / Q000188:drug therapy / Q000523:psychology; D016896:Treatment Outcome